According to the noted expert Dr M.D.Nair, India should seriously consider including utility patents, particularly in pharmaceuticals sector, in the yet-to-be-passed new patent legislation, so that in the emerging post-2000 scenario, the country will have its rightful place as a major contributor to the global phamaceutical industry. The Swiss-type claims are defined as claims for new therapeutic uses of known molecules and this could give great philip to discovery of new uses for traditional medicines and clinical research.Such a new addition could have helpful results in many other areas including materials research.